Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)

  1. Abrisqueta, P.
  2. González-Barca, E.
  3. Ferrà, C.
  4. Ríos-Herranz, E.
  5. Fernández de la Mata, M.
  6. Delgado, J.
  7. Andreu, R.
  8. Hernández-Rivas, J.Á.
  9. Terol, M.J.
  10. Navarro, A.
  11. Vidriales, M.B.
  12. Baltasar, P.
  13. De la Serna, J.
  14. Ramírez, Á.
  15. Ballester, C.
  16. Moreno, C.
  17. García-Marco, J.A.
  18. Córdoba, R.
  19. Yáñez, L.
  20. Casado, L.F.
  21. González, M.
  22. Bosch, F.
Aldizkaria:
eClinicalMedicine

ISSN: 2589-5370

Argitalpen urtea: 2024

Alea: 73

Mota: Artikulua

DOI: 10.1016/J.ECLINM.2024.102642 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus